Clinical trials recruiting in West Mifflin, Pennsylvania
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 2Phase 3 5Not applicable 1
Conditions recruiting in West Mifflin, Pennsylvania
Recruiting trials in West Mifflin, Pennsylvania
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Biennial CEM in Women With a Personal History of Breast Cancer
- Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Common questions
How many clinical trials are recruiting in West Mifflin, Pennsylvania?
7 recruiting trials have at least one study site in West Mifflin, Pennsylvania.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.